Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

Sponsor
Zia, Al Raza (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT01989013
Collaborator
(none)
5
1
1
132.9
0

Study Details

Study Description

Brief Summary

We are studying & researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.

Condition or Disease Intervention/Treatment Phase
  • Other: biweekly intervention
N/A

Detailed Description

We are studying & researching the effect of CranioSacral I therapy on Parkinson's Disease

Study Design

Study Type:
Interventional
Anticipated Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
Study Start Date :
Feb 1, 2014
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Mar 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: biweekly intervention

biweekly intervention

Other: biweekly intervention
10 step craniosacral therapy protocol through manual therapy at feet , thoracic diaphragm, neck and cranium
Other Names:
  • manual therapy
  • Outcome Measures

    Primary Outcome Measures

    1. reduction in tremors due to Parkinson's disease in the patient [3 months]

      Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction

    Secondary Outcome Measures

    1. Quality of Proprioception [3 months]

      will evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.

    Other Outcome Measures

    1. Overall emotional State and sleep quality [3 months]

      will evaluate the overall emotional and sleeping habits on the measurement scale of 1-10 where 1 being emotionally stable and positive with 8 hours of quality sleep and 10 being emotionally unstable and have less than 4 hours of sleep at night and at the end of research will graphically and statistically provide the outcome of the above mentioned measure.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • must be Diagnosed with Parkinson's Disease
    Exclusion Criteria:
    • Anyone without Parkinson's Disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Naturalmed therapy Ann Arbor Michigan United States 48104

    Sponsors and Collaborators

    • Zia, Al Raza

    Investigators

    • Principal Investigator: Al Raza, CST, IBR, Inc.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zia, Al Raza
    ClinicalTrials.gov Identifier:
    NCT01989013
    Other Study ID Numbers:
    • CST001
    First Posted:
    Nov 20, 2013
    Last Update Posted:
    Jul 19, 2021
    Last Verified:
    Jun 1, 2021
    Keywords provided by Zia, Al Raza
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 19, 2021